488 related articles for article (PubMed ID: 28031364)
1. An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.
McCaffrey K; Boo I; Owczarek CM; Hardy MP; Perugini MA; Fabri L; Scotney P; Poumbourios P; Drummer HE
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031364
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region.
Alhammad Y; Gu J; Boo I; Harrison D; McCaffrey K; Vietheer PT; Edwards S; Quinn C; Coulibaly F; Poumbourios P; Drummer HE
J Virol; 2015 Dec; 89(24):12245-61. PubMed ID: 26378182
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal Sequence and Functional Evolution within Glycoprotein E2 in Hepatitis C Virus Genotype 3a Infection.
Alhammad YM; Maharajh S; Butcher R; Eden JS; White PA; Poumbourios P; Drummer HE
PLoS One; 2015; 10(5):e0126397. PubMed ID: 25970466
[TBL] [Abstract][Full Text] [Related]
4. The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity.
McCaffrey K; Gouklani H; Boo I; Poumbourios P; Drummer HE
J Gen Virol; 2011 Jan; 92(Pt 1):112-21. PubMed ID: 20926639
[TBL] [Abstract][Full Text] [Related]
5. Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants.
Khera T; Behrendt P; Bankwitz D; Brown RJP; Todt D; Doepke M; Khan AG; Schulze K; Law J; Logan M; Hockman D; Wong JAJ; Dold L; Gonzalez-Motos V; Spengler U; Viejo-Borbolla A; Ströh LJ; Krey T; Tarr AW; Steinmann E; Manns MP; Klein F; Guzman CA; Marcotrigiano J; Houghton M; Pietschmann T
J Hepatol; 2019 Apr; 70(4):593-602. PubMed ID: 30439392
[TBL] [Abstract][Full Text] [Related]
6. Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2.
Vasiliauskaite I; Owsianka A; England P; Khan AG; Cole S; Bankwitz D; Foung SKH; Pietschmann T; Marcotrigiano J; Rey FA; Patel AH; Krey T
mBio; 2017 May; 8(3):. PubMed ID: 28512091
[TBL] [Abstract][Full Text] [Related]
7. Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis.
Gopal R; Jackson K; Tzarum N; Kong L; Ettenger A; Guest J; Pfaff JM; Barnes T; Honda A; Giang E; Davidson E; Wilson IA; Doranz BJ; Law M
PLoS Pathog; 2017 Dec; 13(12):e1006735. PubMed ID: 29253863
[TBL] [Abstract][Full Text] [Related]
8. Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry.
Prentoe J; Bukh J
Front Immunol; 2018; 9():2146. PubMed ID: 30319614
[TBL] [Abstract][Full Text] [Related]
9. Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.
Bose M; Mullick R; Das S; Das S; Karande AA
Virus Res; 2016 Sep; 224():46-57. PubMed ID: 27574733
[TBL] [Abstract][Full Text] [Related]
10. Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization.
Pierce BG; Keck ZY; Wang R; Lau P; Garagusi K; Elkholy K; Toth EA; Urbanowicz RA; Guest JD; Agnihotri P; Kerzic MC; Marin A; Andrianov AK; Ball JK; Mariuzza RA; Fuerst TR; Foung SKH
J Virol; 2020 Oct; 94(22):. PubMed ID: 32878891
[TBL] [Abstract][Full Text] [Related]
11. Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.
Haddad JG; Rouillé Y; Hanoulle X; Descamps V; Hamze M; Dabboussi F; Baumert TF; Duverlie G; Lavie M; Dubuisson J
J Virol; 2017 Apr; 91(8):. PubMed ID: 28179528
[TBL] [Abstract][Full Text] [Related]
12. Identification of new functional regions in hepatitis C virus envelope glycoprotein E2.
Albecka A; Montserret R; Krey T; Tarr AW; Diesis E; Ball JK; Descamps V; Duverlie G; Rey F; Penin F; Dubuisson J
J Virol; 2011 Feb; 85(4):1777-92. PubMed ID: 21147916
[TBL] [Abstract][Full Text] [Related]
13. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563
[TBL] [Abstract][Full Text] [Related]
14. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding.
Triyatni M; Vergalla J; Davis AR; Hadlock KG; Foung SK; Liang TJ
Virology; 2002 Jun; 298(1):124-32. PubMed ID: 12093180
[TBL] [Abstract][Full Text] [Related]
15. Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding.
McCaffrey K; Boo I; Poumbourios P; Drummer HE
J Virol; 2007 Sep; 81(17):9584-90. PubMed ID: 17581991
[TBL] [Abstract][Full Text] [Related]
16. Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.
Lavie M; Sarrazin S; Montserret R; Descamps V; Baumert TF; Duverlie G; Séron K; Penin F; Dubuisson J
J Virol; 2014 Sep; 88(18):10584-97. PubMed ID: 24990994
[TBL] [Abstract][Full Text] [Related]
17. Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs.
McGregor J; Hardy JM; Lay CS; Boo I; Piontek M; Suckow M; Coulibaly F; Poumbourios P; Center RJ; Drummer HE
J Virol; 2022 Mar; 96(5):e0167521. PubMed ID: 34986001
[TBL] [Abstract][Full Text] [Related]
18. A Novel Approach To Display Structural Proteins of Hepatitis C Virus Quasispecies in Patients Reveals a Key Role of E2 HVR1 in Viral Evolution.
Tong Y; Li Q; Li R; Xu Y; Pan Y; Niu J; Zhong J
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554700
[TBL] [Abstract][Full Text] [Related]
19. Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain.
Moustafa RI; Haddad JG; Linna L; Hanoulle X; Descamps V; Mesalam AA; Baumert TF; Duverlie G; Meuleman P; Dubuisson J; Lavie M
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068644
[TBL] [Abstract][Full Text] [Related]
20. Fine mapping of murine antibody responses to immunization with a novel soluble form of hepatitis C virus envelope glycoprotein complex.
Ruwona TB; Giang E; Nieusma T; Law M
J Virol; 2014 Sep; 88(18):10459-71. PubMed ID: 24965471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
